Results for tag: "Bone Tumor"

Bone tumors are a type of cancer that affects the bones and can be either benign or malignant. Benign bone tumors are non-cancerous and do not spread to other parts of the body. Malignant bone tumors, on the other hand, are cancerous and can spread to other parts of the body. Treatment for bone tumors typically involves surgery, radiation therapy, chemotherapy, and/or targeted therapy. The bone tumor market within the context of oncology is a rapidly growing field due to the increasing prevalence of bone tumors. The market is expected to benefit from the increasing adoption of advanced technologies and the development of novel treatments. Additionally, the rising awareness of bone tumors and the increasing number of clinical trials are expected to drive the growth of the market. Some companies in the bone tumor market include Novartis, Pfizer, Merck, Amgen, and Bristol-Myers Squibb. Additionally, there are several smaller companies that are developing novel treatments for bone tumors, such as ImmunoCellular Therapeutics, OncoMed Pharmaceuticals, and OsteoGeneX. Show Less Read more